Cargando…

Therapeutic effect of various ginsenosides on rheumatoid arthritis

BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease which causes disability and threatens the health of humans. Therefore, it is of great significance to seek novel effective drugs for RA. It has been reported that various ginsenoside monomers are able to treat RA. However, it is still un...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng, Ren, Hongwei, Li, Kun, Xie, Shengsheng, Zhang, Ru, Zhang, Longlong, Xia, Jiaxuan, Chen, Xing, Li, Xilin, Wang, Jianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145820/
https://www.ncbi.nlm.nih.gov/pubmed/34034706
http://dx.doi.org/10.1186/s12906-021-03302-5
_version_ 1783697258205675520
author Zhang, Meng
Ren, Hongwei
Li, Kun
Xie, Shengsheng
Zhang, Ru
Zhang, Longlong
Xia, Jiaxuan
Chen, Xing
Li, Xilin
Wang, Jianxin
author_facet Zhang, Meng
Ren, Hongwei
Li, Kun
Xie, Shengsheng
Zhang, Ru
Zhang, Longlong
Xia, Jiaxuan
Chen, Xing
Li, Xilin
Wang, Jianxin
author_sort Zhang, Meng
collection PubMed
description BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease which causes disability and threatens the health of humans. Therefore, it is of great significance to seek novel effective drugs for RA. It has been reported that various ginsenoside monomers are able to treat RA. However, it is still unclear which ginsenoside is the most effective and has the potential to be developed into an anti-RA drug. METHODS: The ginsenosides, including Rg1, Rg3, Rg5, Rb1, Rh2 and CK, were evaluated and compared for their therapeutic effect on RA. In in vitro cell studies, methotrexate (MTX) and 0.05% dimethyl sulfoxide (DMSO) was set as a positive control group and a negative control group, respectively. LPS-induced RAW264.7 cells and TNF-α-induced HUVEC cells were cultured with MTX, DMSO and six ginsenosides, respectively. Cell proliferation was analyzed by MTT assay and cell apoptosis was carried out by flow cytometry. CIA mice model was developed to evaluate the therapeutic efficacy of ginsenosides. The analysis of histology, immunohistochemistry, flow cytometry and cytokine detections of the joint tissues were performed to elucidate the action mechanisms of ginsenosides. RESULTS: All six ginsenosides showed good therapeutic effect on acute arthritis compared with the negative control group, Ginsenoside CK provided the most effective treatment ability. It could significantly inhibit the proliferation and promote the apoptosis of RAW 264.7 and HUVEC cells, and substantially reduce the swelling, redness, functional impairment of joints and the pathological changes of CIA mice. Meanwhile, CK could increase CD8 + T cell to down-regulate the immune response, decrease the number of activated CD4 + T cell and proinflammatory M1-macrophages, thus resulting in the inhibition of the secretion of proinflammatory cytokine such as TNF-α and IL-6. CONCLUSION: Ginsenoside CK was proved to be a most potential candidate among the tested ginsenosides for the treatment of RA, with a strong anti-inflammation and immune modulating capabilities.
format Online
Article
Text
id pubmed-8145820
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81458202021-05-25 Therapeutic effect of various ginsenosides on rheumatoid arthritis Zhang, Meng Ren, Hongwei Li, Kun Xie, Shengsheng Zhang, Ru Zhang, Longlong Xia, Jiaxuan Chen, Xing Li, Xilin Wang, Jianxin BMC Complement Med Ther Research Article BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease which causes disability and threatens the health of humans. Therefore, it is of great significance to seek novel effective drugs for RA. It has been reported that various ginsenoside monomers are able to treat RA. However, it is still unclear which ginsenoside is the most effective and has the potential to be developed into an anti-RA drug. METHODS: The ginsenosides, including Rg1, Rg3, Rg5, Rb1, Rh2 and CK, were evaluated and compared for their therapeutic effect on RA. In in vitro cell studies, methotrexate (MTX) and 0.05% dimethyl sulfoxide (DMSO) was set as a positive control group and a negative control group, respectively. LPS-induced RAW264.7 cells and TNF-α-induced HUVEC cells were cultured with MTX, DMSO and six ginsenosides, respectively. Cell proliferation was analyzed by MTT assay and cell apoptosis was carried out by flow cytometry. CIA mice model was developed to evaluate the therapeutic efficacy of ginsenosides. The analysis of histology, immunohistochemistry, flow cytometry and cytokine detections of the joint tissues were performed to elucidate the action mechanisms of ginsenosides. RESULTS: All six ginsenosides showed good therapeutic effect on acute arthritis compared with the negative control group, Ginsenoside CK provided the most effective treatment ability. It could significantly inhibit the proliferation and promote the apoptosis of RAW 264.7 and HUVEC cells, and substantially reduce the swelling, redness, functional impairment of joints and the pathological changes of CIA mice. Meanwhile, CK could increase CD8 + T cell to down-regulate the immune response, decrease the number of activated CD4 + T cell and proinflammatory M1-macrophages, thus resulting in the inhibition of the secretion of proinflammatory cytokine such as TNF-α and IL-6. CONCLUSION: Ginsenoside CK was proved to be a most potential candidate among the tested ginsenosides for the treatment of RA, with a strong anti-inflammation and immune modulating capabilities. BioMed Central 2021-05-25 /pmc/articles/PMC8145820/ /pubmed/34034706 http://dx.doi.org/10.1186/s12906-021-03302-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Zhang, Meng
Ren, Hongwei
Li, Kun
Xie, Shengsheng
Zhang, Ru
Zhang, Longlong
Xia, Jiaxuan
Chen, Xing
Li, Xilin
Wang, Jianxin
Therapeutic effect of various ginsenosides on rheumatoid arthritis
title Therapeutic effect of various ginsenosides on rheumatoid arthritis
title_full Therapeutic effect of various ginsenosides on rheumatoid arthritis
title_fullStr Therapeutic effect of various ginsenosides on rheumatoid arthritis
title_full_unstemmed Therapeutic effect of various ginsenosides on rheumatoid arthritis
title_short Therapeutic effect of various ginsenosides on rheumatoid arthritis
title_sort therapeutic effect of various ginsenosides on rheumatoid arthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145820/
https://www.ncbi.nlm.nih.gov/pubmed/34034706
http://dx.doi.org/10.1186/s12906-021-03302-5
work_keys_str_mv AT zhangmeng therapeuticeffectofvariousginsenosidesonrheumatoidarthritis
AT renhongwei therapeuticeffectofvariousginsenosidesonrheumatoidarthritis
AT likun therapeuticeffectofvariousginsenosidesonrheumatoidarthritis
AT xieshengsheng therapeuticeffectofvariousginsenosidesonrheumatoidarthritis
AT zhangru therapeuticeffectofvariousginsenosidesonrheumatoidarthritis
AT zhanglonglong therapeuticeffectofvariousginsenosidesonrheumatoidarthritis
AT xiajiaxuan therapeuticeffectofvariousginsenosidesonrheumatoidarthritis
AT chenxing therapeuticeffectofvariousginsenosidesonrheumatoidarthritis
AT lixilin therapeuticeffectofvariousginsenosidesonrheumatoidarthritis
AT wangjianxin therapeuticeffectofvariousginsenosidesonrheumatoidarthritis